Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 27 May 2024, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net Loss of Fermenta Biotech reported to Rs 6.94 crore in the quarter ended March 2024 as against net loss of Rs 4.11 crore during the previous quarter ended March 2023. Sales declined 7.44% to Rs 97.34 crore in the quarter ended March 2024 as against Rs 105.16 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 23.06 crore in the year ended March 2024 as against net loss of Rs 51.08 crore during the previous year ended March 2023. Sales declined 4.08% to Rs 335.66 crore in the year ended March 2024 as against Rs 349.94 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales97.34105.16 -7 335.66349.94 -4 OPM %5.5318.34 -8.205.03 - PBDT7.3714.14 -48 22.285.42 311 PBT0.917.96 -89 -2.44-22.83 89 NP-6.94-4.11 -69 -23.06-51.08 55 Powered by Capital Market - Live News

Fermenta Biotech announced that the Annual General Meeting(AGM) of the company will be held on 12 August 2024.Powered by Capital Market - Live News

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 27 May 2024Powered by Capital Market - Live News

Net profit of Fermenta Biotech reported to Rs 9.85 crore in the quarter ended December 2023 as against net loss of Rs 37.39 crore during the previous quarter ended December 2022. Sales rose 80.40% to Rs 98.97 crore in the quarter ended December 2023 as against Rs 54.86 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales98.9754.86 80 OPM %25.38-17.90 - PBDT22.46-14.96 LP PBT16.07-21.29 LP NP9.85-37.39 LP Powered by Capital Market - Live News